CompanyGraph
At a glance
- Depends onMidstream position: 6 outgoing, 8 incoming connections
- ScaleMarket cap is $200.95B, higher than 95% of all stocks globally
- FinancialsAltman Z-Score 5.34: safe zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
2.20%Above 5Y avg (1.82%)
Annual Rate
USD 2.52Paid quarterly
Payout Ratio
79.0%Moderate
Consecutive Growth
12 yrStrong track record
Paying Dividends
27 yr
Payback Period
45.4 yr
Last Ex-Dividend
Jul 15, 2026
Last Payment
Aug 17, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
200.95BUSDvs all stocks (USD)
Trailing P/E
37.70xRevenue (TTM)
46.58BUSDvs all stocks (USD)
Profit Margin
11.64%Beta
0.5810xvs all stocks
52-Week Change
-12.68%vs all stocks
Forward Annual Dividend Yield
2.20%vs all stocks
Market Capitalization
200.95BUSDvs all stocks (USD)
Enterprise Value
228.72BUSDvs all stocks (USD)
Trailing P/E
37.70xForward P/E
19.15xPEG Ratio
-0.7831xPrice to Sales (TTM)
4.31xPrice to Book (MRQ)
3.93xEnterprise to Revenue
4.91xEnterprise to EBITDA
19.58xProfit Margin
11.64%Operating Margin
14.71%Return on Assets (TTM)
5.33%Return on Equity (TTM)
10.58%Revenue (TTM)
46.58BUSDvs all stocks (USD)
Revenue per Share (TTM)
26.76USDUpdated Aug 26, 2026Quarterly Revenue Growth
13.00%Gross Profit (TTM)
26.48BUSDvs all stocks (USD)
EBITDA (TTM)
12.03BUSDvs all stocks (USD)
Net Income (TTM)
5.40BUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
-47.80%Operating Cash Flow (TTM)
9.91BUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
7.21BUSDvs all stocks (USD)
Forward Annual Dividend Rate
2.52USDUpdated Aug 26, 2026Forward Annual Dividend Yield
2.20%vs all stocks
Trailing Annual Dividend Rate
2.48USDUpdated Aug 26, 2026Trailing Annual Dividend Yield
2.16%vs all stocks
5-Year Average Dividend Yield
1.82%vs all stocks
Payout Ratio
78.96%Minority Interest (Equity)
641.00MUSDFY2025 · Dec 31, 2025Revenue
44.33BUSDFY2025 · Dec 31, 2025Cost of Goods Sold
19.32BUSDFY2025 · Dec 31, 2025Gross Profit
25.01BUSDFY2025 · Dec 31, 2025Operating Income
8.05BUSDvs all stocks (USD)
Pre-tax Income
8.47BUSDFY2025 · Dec 31, 2025Income Tax Expense
1.94BUSDFY2025 · Dec 31, 2025Net Income
6.52BUSDFY2025 · Dec 31, 2025EBIT
8.96BUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
12.03BUSDFY2025 · Dec 31, 2025Research & Development
2.94BUSDFY2025 · Dec 31, 2025Selling, General & Administrative
12.33BUSDFY2025 · Dec 31, 2025Non-operating Interest Income
308.00MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
493.00MUSDFY2025 · Dec 31, 2025EPS (Basic)
3.76USDFY2025 · Dec 31, 2025EPS (Diluted)
3.72USDFY2025 · Dec 31, 2025Basic Shares Outstanding
1.74BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.74BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
6.52BUSDFY2025 · Dec 31, 2025Operating Cash Flow
10.80BUSDFY2025 · Dec 31, 2025Free Cash Flow
8.63BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
8.52BUSDFY2025 · Dec 31, 2025Income Tax Paid
1.93BUSDFY2025 · Dec 31, 2025Interest Paid
545.00MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
6.52BUSDFY2025 · Dec 31, 2025Depreciation & Amortization
3.12BUSDFY2025 · Dec 31, 2025Stock-based Compensation
664.00MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-652.00MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
954.00MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
195.00MUSDFY2025 · Dec 31, 2025Capital Expenditures
-2.17BUSDFY2025 · Dec 31, 2025Net Acquisitions
-105.00MUSDFY2025 · Dec 31, 2025Purchase of Investments
-167.00MUSDFY2025 · Dec 31, 2025Sale of Investments
3.00MUSDFY2025 · Dec 31, 2025Other Investing Activity
18.00MUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-2.42BUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
5.00MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.50BUSDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-115.00MUSDFY2025 · Dec 31, 2025Common Stock Repurchase
-893.00MUSDFY2025 · Dec 31, 2025Common Dividends Paid
-4.12BUSDFY2025 · Dec 31, 2025Other Financing Charges
-82.00MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
-6.71BUSDFY2025 · Dec 31, 2025Shares Outstanding
1.73BSharesUpdated Aug 26, 2026Float Shares
1.72BSharesUpdated Aug 26, 2026Shares Short
20.38MSharesUpdated Aug 26, 2026Short Ratio
1.85daysvs all stocks
Short % of Shares Outstanding
1.32%vs all stocks
% Held by Insiders
0.50%vs all stocks
% Held by Institutions
81.88%vs all stocks
Total Cash (MRQ)
5.60BUSDvs all stocks (USD)
Total Cash per Share (MRQ)
3.24USDUpdated Aug 26, 2026Total Debt (MRQ)
32.72BUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.6321xCurrent Ratio (MRQ)
1.38xBook Value per Share (MRQ)
29.54USDUpdated Aug 26, 2026Total Assets
86.71BUSDvs all stocks (USD)
Total Current Assets
26.00BUSDFY2025 · Dec 31, 2025Total Liabilities
33.94BUSDFY2025 · Dec 31, 2025Total Non-current Assets
60.72BUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
17.45BUSDFY2025 · Dec 31, 2025Total Current Liabilities
16.50BUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
8.52BUSDFY2025 · Dec 31, 2025Other Short-term Investments
417.00MUSDFY2025 · Dec 31, 2025Accounts Receivable
7.93BUSDFY2025 · Dec 31, 2025Inventory
6.49BUSDFY2025 · Dec 31, 2025Accounts Payable
4.24BUSDFY2025 · Dec 31, 2025Short-term Debt
3.03BUSDFY2025 · Dec 31, 2025Long-term Debt
10.83BUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
2.54BUSDFY2025 · Dec 31, 2025Common Stock (Book)
25.53BUSDFY2025 · Dec 31, 2025Retained Earnings
49.78BUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
52.77BUSDvs all stocks (USD)
Treasury Stock
17.18BUSDFY2025 · Dec 31, 202552-Week Low
81.97USDUpdated Aug 26, 202652-Week High
137.49USDUpdated Aug 26, 202652-Week Change
-12.68%vs all stocks
Beta
0.5810xvs all stocks
50-Day MA
100.48USDUpdated Aug 26, 2026200-Day MA
107.04USDUpdated Aug 26, 2026Avg 10-Day Volume
7.55MSharesUpdated Aug 26, 2026Avg 30-Day Volume
10.30MSharesUpdated Aug 26, 2026Diluted EPS (TTM)
3.08USDUpdated Aug 26, 2026Other Income / Expense
598.00MUSDFY2025 · Dec 31, 2025Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.34: safe zoneNotable
Altman Z-Score: 5.34
High earnings qualityNotable
Earnings Quality Score: 1.04
Supply Chain
Midstream position: 6 outgoing, 8 incoming connectionsNotable
Outgoing: 6.00Incoming: 8.00
High connectivity hub: 14 industry connectionsNotable
Total Connections: 14.00
Scale
Market cap is $200.95B, higher than 95% of all stocks globallySignificant
Market cap (USD): 200,949,412,164Global P95: 25,977,547,947.4
Revenue is $46.58B, higher than 95% of all stocks globallySignificant
Revenue (USD): 46,584,999,936Global P95: 14,960,525,175.39
Levered free cash flow is $7.21B, higher than 95% of all stocks globallySignificant
Levered free cash flow (USD): 7,209,124,864Global P95: 1,224,112,912.614
Companies that share the same coordination system — how they create, deliver, or capture value.
Gilead Sciences Inc.
Tier 1ProductionApproval-Gated PipelineRule
Amgen Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Pfizer Inc.
Tier 1ProductionApproval-Gated PipelineRuleRisk
Novo Nordisk A/S
Tier 1ProductionApproval-Gated PipelineRule
AstraZeneca PLC
Tier 1ProductionApproval-Gated PipelineRuleFlow
Novartis AG
Tier 1ProductionApproval-Gated PipelineRuleRisk
Bristol-Myers Squibb Company
Tier 1ProductionApproval-Gated PipelineRuleFlow
Vertex Pharmaceuticals Incorporated
Tier 1ProductionApproval-Gated PipelineRule
Stryker Corporation
Tier 1ProductionApproval-Gated PipelineRuleFlow
Roche Holding AG Genussscheine
Tier 1ProductionApproval-Gated PipelineRuleRisk